Compare · ADGM vs MDLN
ADGM vs MDLN
Side-by-side comparison of Adagio Medical Holdings Inc (ADGM) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ADGM and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 17011.5x ADGM ($2.8M).
- MDLN has been more active in the news (7 items in the past 4 weeks vs 6 for ADGM).
- MDLN has more recent analyst coverage (25 ratings vs 2 for ADGM).
- Company
- Adagio Medical Holdings Inc
- Medline Inc.
- Price
- $0.10+21.82%
- $35.95-1.74%
- Market cap
- $2.8M
- $48.08B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 6
- 7
- Recent ratings
- 2
- 25
Latest ADGM
- SEC Form 4 filed by Adagio Medical Holdings Inc
- SEC Form DEF 14A filed by Adagio Medical Holdings Inc
- SEC Form 8-K filed by Adagio Medical Holdings Inc
- SEC Form PRE 14A filed by Adagio Medical Holdings Inc
- Adagio Medical Holdings Inc filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits
- Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value
- Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical Center Phoenix
- Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
- Amendment: SEC Form SCHEDULE 13G/A filed by Adagio Medical Holdings Inc
- SEC Form 8-K filed by Adagio Medical Holdings Inc
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M